KNSA
Price
$33.38
Change
+$0.10 (+0.30%)
Updated
Aug 15 closing price
Capitalization
2.47B
79 days until earnings call
TLPH
Price
$0.43
Change
-$0.00 (-0.00%)
Updated
Aug 15 closing price
Capitalization
8.72M
Interact to see
Advertisement

KNSA vs TLPH

Header iconKNSA vs TLPH Comparison
Open Charts KNSA vs TLPHBanner chart's image
Kiniksa Pharmaceuticals International
Price$33.38
Change+$0.10 (+0.30%)
Volume$588.65K
Capitalization2.47B
Talphera
Price$0.43
Change-$0.00 (-0.00%)
Volume$212.83K
Capitalization8.72M
KNSA vs TLPH Comparison Chart in %
Loading...
KNSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KNSA vs. TLPH commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KNSA is a Hold and TLPH is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 18, 2025
Stock price -- (KNSA: $33.38 vs. TLPH: $0.43)
Brand notoriety: KNSA and TLPH are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: KNSA: 69% vs. TLPH: 47%
Market capitalization -- KNSA: $2.47B vs. TLPH: $8.72M
KNSA [@Pharmaceuticals: Generic] is valued at $2.47B. TLPH’s [@Pharmaceuticals: Generic] market capitalization is $8.72M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.3B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KNSA’s FA Score shows that 0 FA rating(s) are green whileTLPH’s FA Score has 0 green FA rating(s).

  • KNSA’s FA Score: 0 green, 5 red.
  • TLPH’s FA Score: 0 green, 5 red.
According to our system of comparison, KNSA is a better buy in the long-term than TLPH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KNSA’s TA Score shows that 5 TA indicator(s) are bullish while TLPH’s TA Score has 3 bullish TA indicator(s).

  • KNSA’s TA Score: 5 bullish, 4 bearish.
  • TLPH’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, KNSA is a better buy in the short-term than TLPH.

Price Growth

KNSA (@Pharmaceuticals: Generic) experienced а +3.83% price change this week, while TLPH (@Pharmaceuticals: Generic) price change was +3.87% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +6.26%. For the same industry, the average monthly price growth was +68.76%, and the average quarterly price growth was +80.82%.

Reported Earning Dates

KNSA is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+6.26% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KNSA($2.47B) has a higher market cap than TLPH($8.72M). KNSA YTD gains are higher at: 68.756 vs. TLPH (-18.842). KNSA has higher annual earnings (EBITDA): 5.98M vs. TLPH (-11.5M). KNSA has more cash in the bank: 308M vs. TLPH (5.39M). TLPH has less debt than KNSA: TLPH (3.37M) vs KNSA (9.77M). KNSA has higher revenues than TLPH: KNSA (529M) vs TLPH (27K).
KNSATLPHKNSA / TLPH
Capitalization2.47B8.72M28,368%
EBITDA5.98M-11.5M-52%
Gain YTD68.756-18.842-365%
P/E Ratio667.60N/A-
Revenue529M27K1,959,259%
Total Cash308M5.39M5,716%
Total Debt9.77M3.37M290%
FUNDAMENTALS RATINGS
KNSA vs TLPH: Fundamental Ratings
KNSA
TLPH
OUTLOOK RATING
1..100
2313
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
51
Fair valued
PROFIT vs RISK RATING
1..100
61100
SMR RATING
1..100
9199
PRICE GROWTH RATING
1..100
3985
P/E GROWTH RATING
1..100
37100
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TLPH's Valuation (51) in the Pharmaceuticals Other industry is somewhat better than the same rating for KNSA (96) in the Pharmaceuticals Major industry. This means that TLPH’s stock grew somewhat faster than KNSA’s over the last 12 months.

KNSA's Profit vs Risk Rating (61) in the Pharmaceuticals Major industry is somewhat better than the same rating for TLPH (100) in the Pharmaceuticals Other industry. This means that KNSA’s stock grew somewhat faster than TLPH’s over the last 12 months.

KNSA's SMR Rating (91) in the Pharmaceuticals Major industry is in the same range as TLPH (99) in the Pharmaceuticals Other industry. This means that KNSA’s stock grew similarly to TLPH’s over the last 12 months.

KNSA's Price Growth Rating (39) in the Pharmaceuticals Major industry is somewhat better than the same rating for TLPH (85) in the Pharmaceuticals Other industry. This means that KNSA’s stock grew somewhat faster than TLPH’s over the last 12 months.

KNSA's P/E Growth Rating (37) in the Pharmaceuticals Major industry is somewhat better than the same rating for TLPH (100) in the Pharmaceuticals Other industry. This means that KNSA’s stock grew somewhat faster than TLPH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KNSATLPH
RSI
ODDS (%)
Bearish Trend 3 days ago
87%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 3 days ago
82%
MACD
ODDS (%)
Bullish Trend 3 days ago
69%
Bullish Trend 3 days ago
73%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
74%
Bullish Trend 5 days ago
77%
Declines
ODDS (%)
Bearish Trend 24 days ago
80%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
79%
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
KNSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IVA4.360.14
+3.32%
Inventiva SA
WU8.360.08
+0.97%
Western Union Company (The)
CRDL1.34N/A
N/A
Cardiol Therapeutics
CRBG33.79-0.45
-1.31%
Corebridge Financial
ASTC5.03-0.07
-1.37%
Astrotech Corp

KNSA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KNSA has been loosely correlated with COYA. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if KNSA jumps, then COYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KNSA
1D Price
Change %
KNSA100%
+0.30%
COYA - KNSA
39%
Loosely correlated
+8.18%
JBIO - KNSA
37%
Loosely correlated
+8.71%
SNDX - KNSA
36%
Loosely correlated
+6.86%
CPRX - KNSA
35%
Loosely correlated
+0.80%
ATXS - KNSA
35%
Loosely correlated
+1.33%
More

TLPH and

Correlation & Price change

A.I.dvisor tells us that TLPH and LVZPF have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TLPH and LVZPF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TLPH
1D Price
Change %
TLPH100%
-0.99%
LVZPF - TLPH
31%
Poorly correlated
N/A
TXMD - TLPH
27%
Poorly correlated
+1.71%
HROW - TLPH
23%
Poorly correlated
-2.97%
RDY - TLPH
22%
Poorly correlated
+0.78%
KNSA - TLPH
20%
Poorly correlated
+0.30%
More